Deca-Durabolin 50 mg, Injektionslösung (i.m.)

7680266600683 CH-26660 Injektionslösung
Deca-Durabolin 50 mg, Injektionslösung (i.m.)
Deca-Durabolin 50 mg, Injektionslösung (i.m.)
Deca-Durabolin 50 mg, Injektionslösung (i.m.)
1 / 3
google

Article details

Package size
1 x 1 ml
Selling units
1
Measure
Ampulle(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
08/01/2025
Summary of Product Characteristics
Français
08/01/2025
Summary of Product Characteristics
Italien
08/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
0.1 ML Substance HBESI
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 17.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1962

Authorization holder

Aspen Pharma Schweiz GmbH

6340 Baar

Authorization information

Swissmedic authorization number
26660
Drug name
Deca-Durabolin, Injektionslösung (i.m.)
Galenic form
LSINJ
ATC Code
A14AB01
Authorization status
Z
Dispensing category
B
First authorization
05/10/1960
Authorization expiration date
31/12/9999
IT Number
07.08.5.
Domain
Human medicine
Field of application
Nachgewiesene Osteoporose bei postmenopausalen Frauen

Package details

Description (FR)
DECA-DURABOLIN sol inj 50 mg i.m. amp 1 ml
Description (DE)
DECA-DURABOLIN Inj Lös 50 mg i.m. Amp 1 ml
Market launch
05/10/1960
Narcotic (BTM)
No

Other package sizes (3)

None
3 x 1 mL AMP
GTIN: None
Not in V1
DECA DURABOLIN sol inj 50 mg i.m. 10 amp 1 ml
None None
GTIN: 7680266601222
Not in V1
None
None None
GTIN: None
Not in V1